London, United Kingdom
Huma, a pioneering global healthcare AI company, is renowned for its mission to accelerate digital solution adoption in both care and research. Since its founding in 2011, Huma has established a significant presence in the healthcare industry with its robust technology, powering over 3,000 hospitals and clinics across 70+ countries.
The company's flagship product has earned critical regulatory clearances, including FDA 510(k) Class II, EU/MDR Class IIb, and Saudi FDA Class C, highlighting its readiness for extensive healthcare applications. With 1.8 million active users, Huma stands out as a key player in major national healthcare initiatives worldwide.
Recently, Huma completed a $80.00M Series D investment round, backed by industry giants like Leaps by Bayer, HAT SGR, Hitachi, and AstraZeneca. This substantial funding underlines investor confidence in Huma's capacity to drive market innovation. Headquartered in the United Kingdom, Huma continues to engage the healthcare ecosystem with its cutting-edge solutions.
